Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CRC, . Treffer: 116

2023

Jakubauskas, M; Jakubauskiene, L; Leber, B; Horvath, A; Strupas, K; Stiegler, P; Schemmer, P Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model.
Nutrients. 2023; 15(5): Doi: 10.3390/nu15051117 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kendzia, S; Franke, S; Kröhler, T; Golob-Schwarzl, N; Schweiger, C; Toeglhofer, AM; Skofler, C; Uranitsch, S; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Yaspo, ML; Reinhard, C; Schäfer, R; Keilholz, U; Regenbrecht, C; Schicho, R; Fickert, P; Lax, SF; Erdmann, F; Schulz, MH; Kiemer, AK; Haybaeck, J; Kessler, SM A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Mol Cancer. 2023; 22(1):89 Doi: 10.1186/s12943-023-01787-x
PubMed FullText FullText_MUG

 

2022

Agamennone, V; Abuja, PM; Basic, M; De, Angelis, M; Gessner, A; Keijser, B; Larsen, M; Pinart, M; Nimptsch, K; Pujos-Guillot, E; Schlicht, K; Sharon, I; Untersmayr, E; Laudes, M; Pischon, T; Bouwman, J; On, Behalf, Of, The, Consortium HDHL-INTIMIC: A European Knowledge Platform on Food, Diet, Intestinal Microbiomics, and Human Health.
Nutrients. 2022; 14(9): Doi: 10.3390/nu14091881 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bajrić, T; Kornprat, P; Faschinger, F; Werkgartner, G; Mischinger, HJ; Wagner, D Sarcopenia and primary tumor location influence patients outcome after liver resection for colorectal liver metastases.
Eur J Surg Oncol. 2022; 48(3):615-620 Doi: 10.1016/j.ejso.2021.09.010
Web of Science PubMed FullText FullText_MUG

 

Boos, SL; Loevenich, LP; Vosberg, S; Engleitner, T; Öllinger, R; Kumbrink, J; Rokavec, M; Michl, M; Greif, PA; Jung, A; Hermeking, H; Neumann, J; Kirchner, T; Rad, R; Jung, P Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
Cell Mol Gastroenterol Hepatol. 2022; 13(2): 517-540. Doi: 10.1016/j.jcmgh.2021.10.008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Cizauskaite, A; Simcikas, D; Schultze, D; Kallifatidis, G; Bruns, H; Cekauskas, A; Herr, I; Bausys, A; Strupas, K; Schemmer, P Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells
ONCOL REP. 2022; 48(5): 205 Doi: 10.3892/or.2022.8420
Web of Science PubMed FullText FullText_MUG

 

Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Sanoyan, DA; Maas, C; Uhlig, J; Fenchel, K; Greil, R; VON, DER, Heyde, E; Agocs, GR; Weide, R; Schwager, M; Reichenbach, F; Modest, DP; Fritsch, R Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC.
Anticancer Res. 2022; 42(10):4773-4785 Doi: 10.21873/anticanres.15982
Web of Science PubMed FullText FullText_MUG

 

Jakubauskas, M; Jakubauskiene, L; Leber, B; Horvath, A; Strupas, K; Stiegler, P; Schemmer, P Probiotic Supplementation Suppresses Tumor Growth in an Experimental Colorectal Cancer Liver Metastasis Model.
INT J MOL SCI. 2022; 23(14): 7674 Doi: 10.3390/ijms23147674 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Palles, C; Martin, L; Domingo, E; Chegwidden, L; McGuire, J; Cuthill, V; Heitzer, E; Kerr, R; Kerr, D; Kearsey, S; Clark, SK; Tomlinson, I; Latchford, A, , CORGI, Consortium The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.
Fam Cancer. 2022; Doi: 10.1007/s10689-021-00256-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Grbčić, P; Eichmann, TO; Kraljević, Pavelić, S; Sedić, M The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
Int J Mol Sci. 2021; 22(19): Doi: 10.3390/ijms221910767 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Heuberger, J; Grinat, J; Kosel, F; Liu, L; Kunz, S; Vidal, RO; Keil, M; Haybaeck, J; Robine, S; Louvard, D; Regenbrecht, C; Sporbert, A; Sauer, S; von Eyss, B; Sigal, M; Birchmeier, W High Yap and Mll1 promote a persistent regenerative cell state induced by Notch signaling and loss of p53.
Proc Natl Acad Sci U S A. 2021; 118(22): Doi: 10.1073/pnas.2019699118 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kumpitsch, C; Fischmeister, FPS; Mahnert, A; Lackner, S; Wilding, M; Sturm, C; Springer, A; Madl, T; Holasek, S; Högenauer, C; Berg, IA; Schoepf, V; Moissl-Eichinger, C Reduced B12 uptake and increased gastrointestinal formate are associated with archaeome-mediated breath methane emission in humans.
Microbiome. 2021; 9(1):193 Doi: 10.1186/s40168-021-01130-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kvietkauskas, M; Zitkute, V; Leber, B; Strupas, K; Stiegler, P; Schemmer, P Dietary Melatonin and Glycine Decrease Tumor Growth through Antiangiogenic Activity in Experimental Colorectal Liver Metastasis.
Nutrients. 2021; 13(6): Doi: 10.3390/nu13062035 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Margonis, GA; Amini, N; Buettner, S; Kim, Y; Wang, J; Andreatos, N; Wagner, D; Sasaki, K; Beer, A; Kamphues, C; Morioka, D; Løes, IM; Imai, K; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Burkhart, R; Endo, I; Baba, H; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
Ann Surg. 2021; 273(6):1165-1172 Doi: 10.1097/SLA.0000000000003504
Web of Science PubMed FullText FullText_MUG

 

Marthin, JK; Lucas, JS; Boon, M; Casaulta, C; Crowley, S; Destouches, DMS; Eber, E; Escribano, A; Haarman, E; Hogg, C; Maitre, B; Marsh, G; Martinu, V; Moreno-Galdó, A; Mussaffi, H; Omran, H; Pohunek, P; Rindlisbacher, B; Robinson, P; Snijders, D; Walker, WT; Yiallouros, P; Johansen, HK; Nielsen, KG International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives.
ERJ Open Res. 2021; 7(3): Doi: 10.1183/23120541.00301-2021 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Miknevicius, P; Zulpaite, R; Leber, B; Strupas, K; Stiegler, P; Schemmer, P The Impact of Probiotics on Intestinal Mucositis during Chemotherapy for Colorectal Cancer: A Comprehensive Review of Animal Studies.
Int J Mol Sci. 2021; 22(17): Doi: 10.3390/ijms22179347 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Najumudeen, AK; Ceteci, F; Fey, SK; Hamm, G; Steven, RT; Hall, H; Nikula, CJ; Dexter, A; Murta, T; Race, AM; Sumpton, D; Vlahov, N; Gay, DM; Knight, JRP; Jackstadt, R; Leach, JDG; Ridgway, RA; Johnson, ER; Nixon, C; Hedley, A; Gilroy, K; Clark, W; Malla, SB; Dunne, PD; Rodriguez-Blanco, G; Critchlow, SE; Mrowinska, A; Malviya, G; Solovyev, D; Brown, G; Lewis, DY; Mackay, GM; Strathdee, D; Tardito, S; Gottlieb, E; Takats, Z; Barry, ST; Goodwin, RJA; Bunch, J; Bushell, M; Campbell, AD; Sansom, OJ, , CRUK, Rosetta, Grand, Challenge, Consortium The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Nat Genet. 2021; 53(1):16-26 Doi: 10.1038/s41588-020-00753-3
Web of Science PubMed FullText FullText_MUG

 

Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; StÖger, H; Gerger, A; Riedl, JM The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021; 41(1):429-436 Doi: 10.21873/anticanres.14792
Web of Science PubMed FullText FullText_MUG

 

Unseld, M; Belic, J; Pierer, K; Zhou, Q; Moser, T; Bauer, R; Piringer, G; Gerger, A; Siebenhüner, A; Speicher, M; Heitzer, E; Prager, GW A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Int J Cancer. 2021; 148(6):1452-1461 Doi: 10.1002/ijc.33303 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Arriga, R; Caratelli, S; Lanzilli, G; Ottaviani, A; Cenciarelli, C; Sconocchia, T; Spagnoli, GC; Iezzi, G; Roselli, M; Lauro, D; Coppola, A; Dotti, G; Ferrone, S; Sconocchia, G CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
Int J Cancer. 2020; 146(9):2531-2538 Doi: 10.1002/ijc.32618 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bianconi, D; Herac, M; Posch, F; Schmeidl, M; Unseld, M; Kieler, M; Brettner, R; Mullauer, L; Riedl, J; Gerger, A; Scheithauer, W; Prager, G Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
THER ADV MED ONCOL. 2020; 12: 1758835920928635 Doi: 10.1177/1758835920928635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Caratelli, S; Arriga, R; Sconocchia, T; Ottaviani, A; Lanzilli, G; Pastore, D; Cenciarelli, C; Venditti, A; Del Principe, MI; Lauro, D; Landoni, E; Du, H; Savoldo, B; Ferrone, S; Dotti, G; Sconocchia, G In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Int J Cancer. 2020; 146(1):236-247 Doi: 10.1002/ijc.32663 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kienzl, M; Hasenoehrl, C; Valadez-Cosmes, P; Maitz, K; Sarsembayeva, A; Sturm, E; Heinemann, A; Kargl, J; Schicho, R IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils.
ONCOIMMUNOLOGY. 2020; 9(1): 1776059 Doi: 10.1080/2162402X.2020.1776059 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kvietkauskas, M; Zitkute, V; Leber, B; Strupas, K; Stiegler, P; Schemmer, P The role of melatonin in colorectal cancer treatment: a comprehensive review.
Ther Adv Med Oncol. 2020; 12(9):1758835920931714-1758835920931714 Doi: 10.1177/1758835920931714 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moik, F; Posch, F; Grilz, E; Scheithauer, W; Pabinger, I; Prager, G; Ay, C Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.
Thromb Res. 2020; 187:9-17 Doi: 10.1016/j.thromres.2020.01.002 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pichler, M; Rodriguez-Aguayo, C; Nam, SY; Dragomir, MP; Bayraktar, R; Anfossi, S; Knutsen, E; Ivan, C; Fuentes-Mattei, E; Lee, SK; Ling, H; Catela Ivkovic, T; Huang, G; Huang, L; Okugawa, Y; Katayama, H; Taguchi, A; Bayraktar, E; Bhattacharya, R; Amero, P; He, WR; Tran, AM; Vychytilova-Faltejskova, P; Klec, C; Bonilla, DL; Zhang, X; Kapitanovic, S; Loncar, B; Gafà, R; Wang, Z; Cristini, V; Hanash, SM; Bar-Eli, M; Lanza, G; Slaby, O; Goel, A; Rigoutsos, I; Lopez-Berestein, G; Calin, GA Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.
Gut. 2020; 69(10): 1818-1831. Doi: 10.1136/gutjnl-2019-318903 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Scherr, AL; Mock, A; Gdynia, G; Schmitt, N; Heilig, CE; Korell, F; Rhadakrishnan, P; Hoffmeister, P; Metzeler, KH; Schulze-Osthoff, K; Illert, AL; Boerries, M; Trojan, J; Waidmann, O; Falkenhorst, J; Siveke, J; Jost, PJ; Bitzer, M; Malek, NP; Vecchione, L; Jelas, I; Brors, B; Glimm, H; Stenzinger, A; Grekova, SP; Gehrig, T; Schulze-Bergkamen, H; Jäger, D; Schirmacher, P; Heikenwalder, M; Goeppert, B; Schneider, M; Fröhling, S; Köhler, BC Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.
Cell Death Dis. 2020; 11(10):875 Doi: 10.1038/s41419-020-03092-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Cancers (Basel). 2020; 12(5): 1200 Doi: 10.3390/cancers12051200 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zhou, Q; Perakis, SO; Ulz, P; Mohan, S; Riedl, JM; Talakic, E; Lax, S; Tötsch, M; Hoefler, G; Bauernhofer, T; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Genome Med. 2020; 12(1):20 Doi: 10.1186/s13073-020-0719-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Barth, DA; Slaby, O; Klec, C; Juracek, J; Drula, R; Calin, GA; Pichler, M Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2019; 11(10): Doi: 10.3390/cancers11101580 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Grill, M; Högenauer, C; Blesl, A; Haybaeck, J; Golob-Schwarzl, N; Ferreirós, N; Thomas, D; Gurke, R; Trötzmüller, M; Köfeler, HC; Gallé, B; Schicho, R Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer.
Sci Rep. 2019; 9(1): 2358-2358. Doi: 10.1038/s41598-019-38865-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Katholnig, K; Schütz, B; Fritsch, SD; Schörghofer, D; Linke, M; Sukhbaatar, N; Matschinger, JM; Unterleuthner, D; Hirtl, M; Lang, M; Herac, M; Spittler, A; Bergthaler, A; Schabbauer, G; Bergmann, M; Dolznig, H; Hengstschläger, M; Magnuson, MA; Mikula, M; Weichhart, T Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis.
JCI Insight. 2019; 4(20): Doi: 10.1172/jci.insight.124164 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Klement, RJ; Abbasi-Senger, N; Adebahr, S; Alheid, H; Allgaeuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Eble, MJ; Ernst, I; Gerum, S; Habermehl, D; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, ND; Krempien, R; Lewitzki, V; Lohaus, F; Ostheimer, C; Papachristofilou, A; Petersen, C; Rieber, J; Schneider, T; Schrade, E; Semrau, R; Wachter, S; Wittig, A; Guckenberger, M; Andratschke, N The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
BMC Cancer. 2019; 19(1):173 Doi: 10.1186/s12885-019-5362-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Liebs, S; Keilholz, U; Kehler, I; Schweiger, C; Haybäck, J; Nonnenmacher, A Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Cancer Med. 2019; 8(8):3761-3769 Doi: 10.1002/cam4.2219 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Marcuello, M; Vymetalkova, V; Neves, RPL; Duran-Sanchon, S; Vedeld, HM; Tham, E; van Dalum, G; Flügen, G; Garcia-Barberan, V; Fijneman, RJ; Castells, A; Vodicka, P; Lind, GE; Stoecklein, NH; Heitzer, E; Gironella, M Circulating biomarkers for early detection and clinical management of colorectal cancer.
MOL ASPECTS MED. 2019; 69(9): 107-122. Doi: 10.1016/j.mam.2019.06.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Fröhlich, E; Mannweiler, S; Meindl, C; Absenger-Novak, M; Hutterer, GC; Seles, M; Augustin, H; Chromecki, TF; Jesche-Chromecki, J; Pummer, K; Zigeuner, R Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.
Cent European J Urol. 2019; 72(1): 23-31. Doi: 10.5173/ceju.2018.1858 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schumacher, D; Andrieux, G; Boehnke, K; Keil, M; Silvestri, A; Silvestrov, M; Keilholz, U; Haybaeck, J; Erdmann, G; Sachse, C; Templin, M; Hoffmann, J; Boerries, M; Schäfer, R; Regenbrecht, CRA Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures.
PLoS Genet. 2019; 15(3):e1008076-e1008076 Doi: 10.1371/journal.pgen.1008076 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, MA; Kashofer, K; Riedl, JM; Stotz, M; Gerger, A Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
Anticancer Res. 2019; 39(2): 847-852. Doi: 10.21873/anticanres.13184
Web of Science PubMed FullText FullText_MUG

 

2018

Deshwar, A; Margonis, GA; Andreatos, N; Barbon, C; Wang, J; Buettner, S; Wagner, D; Sasaki, K; Beer, A; Løes, IM; Pikoulis, E; Damaskos, C; Garmpis, N; Kamphues, K; He, J; Kaczirek, K; Poultsides, G; Lønning, PE; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
Anticancer Res. 2018; 38(5):2891-2895 Doi: 10.21873/anticanres.12535 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hasenoehrl, C; Feuersinger, D; Sturm, EM; Bärnthaler, T; Heitzer, E; Graf, R; Grill, M; Pichler, M; Beck, S; Butcher, L; Thomas, D; Ferreirós, N; Schuligoi, R; Schweiger, C; Haybaeck, J; Schicho, R G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
Int J Cancer. 2018; 142(1):121-132 Doi: 10.1002/ijc.31030 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Plath, J; Siebenhofer, A; Guethlin, C; Blumenstein, I Screening interval recommendations following a normal colonoscopy in individuals with a familial risk of colorectal cancer.
Z Gastroenterol. 2018; 56(4):361-364 Doi: 10.1055/s-0043-123882
Web of Science PubMed FullText FullText_MUG

 

Plath, J; Siebenhofer, A; Haug, U; Koné, I; Hechtner, M; Blumenstein, I; Schulz-Rothe, S; Gerlach, FM; Guethlin, C Utilization of colonoscopy and colonoscopic findings among individuals aged 40-54 years with a positive family history of colorectal cancer: a cross-sectional study in general practice.
Eur J Cancer Prev. 2018; 27(6):539-545 Doi: 10.1097/CEJ.0000000000000399
Web of Science PubMed FullText FullText_MUG

 

Plath, J; Siebenhofer, A; Schulz-Rothe, S; Güthlin, C [Who Should Provide Persons with Familial Risk of Colorectal Cancer with Information on Early Detection? - The View of those Affected].
Gesundheitswesen. 2018; 80(10):878-881 Doi: 10.1055/s-0042-124671
Web of Science PubMed FullText FullText_MUG

 

Posch, F; Silina, K; Leibl, S; Mündlein, A; Moch, H; Siebenhüner, A; Samaras, P; Riedl, J; Stotz, M; Szkandera, J; Stöger, H; Pichler, M; Stupp, R; van den Broek, M; Schraml, P; Gerger, A; Petrausch, U; Winder, T Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Oncoimmunology. 2018; 7(2):e1378844-e1378844 Doi: 10.1080/2162402X.2017.1378844 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rubio, CA; Langner, C; Schmidt, PT Partial to complete abrogation of the subepithelial macrophage barrier against the gut microbiota in patients with ulcerative colitis and Crohn's colitis.
Histopathology. 2018; 72(4):580-587 Doi: 10.1111/his.13417
Web of Science PubMed FullText FullText_MUG

 

Shen, P; Reineke, LC; Knutsen, E; Chen, M; Pichler, M; Ling, H; Calin, GA Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.
Mol Oncol. 2018; 12(11): 1856-1870. Doi: 10.1002/1878-0261.12384 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weis, CA; Kather, JN; Melchers, S; Al-Ahmdi, H; Pollheimer, MJ; Langner, C; Gaiser, T Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Diagn Pathol. 2018; 13(1):64-64 Doi: 10.1186/s13000-018-0739-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zöchmeister, C; Brezina, S; Hofer, P; Baierl, A; Bergmann, MM; Bachleitner-Hofmann, T; Karner-Hanusch, J; Stift, A; Gerger, A; Leeb, G; Mach, K; Rachakonda, S; Kumar, R; Gsur, A Leukocyte telomere length throughout the continuum of colorectal carcinogenesis.
Oncotarget. 2018; 9(17): 13582-13592. Doi: 10.18632/oncotarget.24431 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum